Skip to product information
1 of 1

ERG245

ERG245

Size

SKU:QM-0130381-01

£238.32 GBP
Sale Sold out
Quantity

Request quote or documents

View full details
  • Description

    ERG245 is a BCAT1 inhibitor that enhances oxidative phosphorylation (OXPHOS) in CD8+ T cells by specifically inhibiting BCAT1 activity, thereby increasing the cytotoxicity of CD8+ T cells. ERG245, in combination with Pembrolizumab (anti-PD-1, HY-P9902A), promotes tumor regression. ERG245 can be used in research related to immuno-oncology[1].

  • Molecular Formula

    C17H15BrO3

  • Molecular Weight

    347.2

  • Smiles

    OC(CCC(C(C1=CC=C(Br)C=C1)=O)C2=CC=CC=C2)=O

  • Target

    Aminotransferases (Transaminases)

  • Purity

    99.49

  • Solubility

    DMSO : 100 mg/mL (ultrasonic)

  • Storage Conditions

    4°C (Powder, stored under nitrogen)

  • Shipping Conditions

    Room Temperature

Your cart
Variant Variant total Quantity Price Variant total
5 mgQM-0130381-01
5 mgQM-0130381-01
£238.32/ea
£0.00
£238.32/ea £0.00
10 mgQM-0130381-02
10 mgQM-0130381-02
£351.32/ea
£0.00
£351.32/ea £0.00
25 mgQM-0130381-03
25 mgQM-0130381-03
£652.64/ea
£0.00
£652.64/ea £0.00
50 mgQM-0130381-04
50 mgQM-0130381-04
£1,009.85/ea
£0.00
£1,009.85/ea £0.00
100 mgQM-0130381-05
100 mgQM-0130381-05
£1,580.90/ea
£0.00
£1,580.90/ea £0.00

View cart
0

Total items

£0.00

Product subtotal

Taxes, discounts and shipping calculated at checkout.
View cart

ERG245

ERG245 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.